Skip to main content
European Commission logo
Public Health

Video clip - Meet the European Patient Advocacy Group representative from the European Reference Network on rare kidney diseases, ERKNet

  • News announcement
  • 29 October 2025
  • Directorate-General for Health and Food Safety
  • 1 min read

The founder and CEO of the Cure Lowe’s Foundation has more than an academic interest in finding a cure for Lowe’s Syndrome. Two years ago, his own son was diagnosed with the Lowe’s Syndrome at birth and faces certain kidney failure in the future unless the disease’s progress can be halted. 

He is optimistic, both for his son and for others in need of successful treatments for rare kidney disorders.  The solution his foundation is working on is a patient-led research project bringing industry and researchers together to develop gene therapy for Lowes Syndrome and Dents disease type 2.   Pre-clinical models have shown that the therapy delivers to the right cells.   The Cure Lowe’s Foundation is looking for collaborators, researchers and pioneers to further this promising research.

Video clip on Youtube

Disclaimer: If you have any concerns or questions about the use of your personal data in YouTube, you should read its privacy policies carefully.

Publication date
29 October 2025
Author
Directorate-General for Health and Food Safety